Exact Mass: 853.3309386

Exact Mass Matches: 853.3309386

Found 90 metabolites which its exact mass value is equals to given mass value 853.3309386, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Paclitaxel

Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alpha-R*,beta-S*),11-alpha,12-alpha,12a-alpha, 12b-alpha))-

C47H51NO14 (853.3309386)


Taxol appears as needles (from aqueous methanol) or fine white powder. An anti-cancer drug. Paclitaxel is a tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name taxol is now limited, as Taxol is a registered trade mark. It has a role as a microtubule-stabilising agent, a metabolite, a human metabolite and an antineoplastic agent. It is a tetracyclic diterpenoid and a taxane diterpenoid. It is functionally related to a baccatin III. Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree which contains endophytic fungi that synthesize paclitaxel. It is available as an intravenous solution for injection and the newer formulation contains albumin-bound paclitaxel marketed under the brand name Abraxane. Paclitaxel is a Microtubule Inhibitor. The physiologic effect of paclitaxel is by means of Microtubule Inhibition. Paclitaxel is an antineoplastic agent which acts by inhibitor of cellular mitosis and which currently plays a central role in the therapy of ovarian, breast, and lung cancer. Therapy with paclitaxel has been associated with a low rate of serum enzyme elevations, but has not been clearly linked to cases of clinically apparent acute liver injury. Paclitaxel is a natural product found in Taxomyces andreanae, Penicillium aurantiacobrunneum, and other organisms with data available. Paclitaxel is a compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04) A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS brevifolia. It stabilizes microtubules in their polymerized form leading to cell death. ABI-007 (Abraxane) is the latest attempt to improve upon paclitaxel, one of the leading chemotherapy treatments. Both drugs contain the same active agent, but Abraxane is delivered by a nanoparticle technology that binds to albumin, a natural protein, rather than the toxic solvent known as Cremophor. It is thought that delivering paclitaxel with this technology will cause fewer hypersensitivity reactions and possibly lead to greater drug uptake in tumors. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a US National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani isolated it from the bark of the Pacific yew tree, Taxus brevifolia and named it taxol. Later it was discovered that endophytic fungi in the bark synthesize paclitaxel. See also: Paclitaxel Poliglumex (is active moiety of). A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS brevifolia. It stabilizes microtubules in their polymerized form leading to cell death. [PubChem] ABI-007 (Abraxane) is the latest attempt to improve upon paclitaxel, one of the leading chemotherapy treatments. Both drugs contain the same active agent, but Abraxane is delivered by a nanoparticle technology that binds to albumin, a natural protein, rather than the toxic solvent known as Cremophor. It is thought that delivering paclitaxel with this technology will cause fewer hypersensitivity reactions and possibly lead to greater drug uptake in tumors. A tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name taxol is now limited, as Taxol is a registered trade mark. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CD - Taxanes C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent [Raw Data] CB246_Paclitaxel_pos_20eV_CB000085.txt [Raw Data] CB246_Paclitaxel_pos_10eV_CB000085.txt [Raw Data] CB246_Paclitaxel_pos_30eV_CB000085.txt [Raw Data] CB246_Paclitaxel_pos_40eV_CB000085.txt [Raw Data] CB246_Paclitaxel_pos_50eV_CB000085.txt Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2]. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2].

   

Lacto-n-fucopentaose I

N-[(2S,3R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-4-{[(2R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidate

C32H55NO25 (853.306302)


Lacto-n-fucopentaose I is an oligosaccharide found in human milk and other biofluids. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-n-fucopentaose I and its sulfated and sialylated analogs, SuLNFPI and SLNFPI, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. Burkinabe women show lower concentrations of lacto-n-fucopentaose I while Italian women show a higher concentrations of lacto-n-fucopentaose I. Lacto-n-fucopentaose I inhibits blastocyst attachment to uterine epithelial cells in vitro; component(s) carrying LNF-1 in the secretion might be regulatory molecules helping to secure the proper time for implantation. (PMID: 8639679, 16954962, 1802622, 3927775, 2988366) [HMDB] Lacto-n-fucopentaose I is an oligosaccharide found in human milk and other biofluids. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-n-fucopentaose I and its sulfated and sialylated analogs, SuLNFPI and SLNFPI, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. Burkinabe women show lower concentrations of lacto-n-fucopentaose I while Italian women show a higher concentrations of lacto-n-fucopentaose I. Lacto-n-fucopentaose I inhibits blastocyst attachment to uterine epithelial cells in vitro; component(s) carrying LNF-1 in the secretion might be regulatory molecules helping to secure the proper time for implantation. (PMID: 8639679, 16954962, 1802622, 3927775, 2988366).

   

Lacto-N-fucopentaose-2

N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.306302)


Lacto-N-fucopentaose-2 is an oligosaccharide found in human milk and other biofluids. Lacto-N-fucopentaose-2 is an active pentasaccharide of the blood group Lewisa (Lea). Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-N-fucopentaose-2 and its sulfated and sialylated analogs, SuLNFPII and SLNFPII, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. (PMID: 8639679) [HMDB] Lacto-N-fucopentaose-2 is an oligosaccharide found in human milk and other biofluids. Lacto-N-fucopentaose-2 is an active pentasaccharide of the blood group Lewisa (Lea). Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. Lacto-N-fucopentaose-2 and its sulfated and sialylated analogs, SuLNFPII and SLNFPII, are potent oligosaccharide ligands for the animal lectins, E- and L-selectin, and the natural killer cell receptor, NKR-P1. (PMID: 8639679).

   

Lacto-N-fucopentaose III

N-[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.306302)


Lacto-N-fucopentaose III is an oligosaccharide found in human milk. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. (PMID:17002410) [HMDB] Lacto-N-fucopentaose III is an oligosaccharide found in human milk. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. (PMID:17002410).

   

Lex-lactose

N-[(2S,4R,6R)-2-{[(4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-5-{[(2S,3R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.306302)


Lacto-N-fucopentaose III (LNFPIII) is a polylactosamine sugar, predominant carbohydrate found in S. mansoni egg Ag. Lewis type carbohydrate LNFPIII can function as an adjuvant by their ability to induce a Th2 response (PMID:11418681). LNFPIII/LeX is also expressed by immunosuppressive helminth parasites, by bacteria, and on a number of tumor/cancer cells. According to Atochina et al., LNFPIII-stimulated macrophages secrete prostaglandin E(2), interleukin-10 (IL-10), and tumor necrosis factor alpha (TNF-alpha) but a very low level of IL-12. Interestingly, addition of anti-TNF-alpha, anti-IL-10, or anti-IL-12 monoclonal antibodies did not significantly alter NK cell activity. It shows that soluble mediators are not critical for LNFPIII-stimulated macrophage activation of NK cells and provide further evidence for the importance of cell-cell contact and CD40-CD40L interactions between macrophages and NK cells. (PMID:16148169). Lacto-N-fucopentaose III (LNFPIII) is a polylactosamine sugar, predominant carbohydrate found in S. mansoni egg Ag. Lewis type carbohydrate LNFPIII can function as an adjuvant by their ability to induce a Th2 response (PMID:11418681)

   

Lacto-N-fucopentaose V

N-[(3R,5S,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(3R,5R)-1,2,5-trihydroxy-6-oxo-4-{[(2S,3S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}oxan-4-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-{[(3R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]ethanimidate

C32H55NO25 (853.306302)


Lacto-N-fucopentaose V is an oligosaccharide found in human milk and other biofluids. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. (PMID: 17002410, 16954962, 1802622, 3927775, 6638472) [HMDB] Lacto-N-fucopentaose V is an oligosaccharide found in human milk and other biofluids. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. A recent hypothesis proposes that they could be substrates for the development of the intestinal microflora and the mucosal immune system. Oligosaccharides of the blood group family decorate diverse glycoproteins and glycolipids on the surface of cells. (PMID: 17002410, 16954962, 1802622, 3927775, 6638472).

   

7-Epi-Taxol

N-(3-{[4,12-bis(acetyloxy)-2-(benzoyloxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0,.0,]heptadec-13-en-15-yl]oxy}-2-hydroxy-3-oxo-1-phenylpropyl)benzenecarboximidate

C47H51NO14 (853.3309386)


   

Milataxel

4-(acetyloxy)-15-[(3-{[(tert-butoxy)carbonyl]amino}-3-(furan-2-yl)-2-hydroxypropanoyl)oxy]-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-(propanoyloxy)-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate

C44H55NO16 (853.3520669999999)


   

Lewis X antigen

N-(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl)ethanimidate

C32H55NO25 (853.306302)


   

Onxol

Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR- (2aalpha,4alpha,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-

C47H51NO14 (853.3309386)


7-epi-Taxol is a natural product found in Corylus avellana, Taxus wallichiana, and other organisms with data available. A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death. 7-epi-Taxol is an active metabolite of taxol, with activity comparable to that of taxol against cell replication, promoting microtubule bundle formation and against microtubule depolymerization. 7-epi-Taxol is an active metabolite of taxol, with activity comparable to that of taxol against cell replication, promoting microtubule bundle formation and against microtubule depolymerization.

   

1-Hydroxysulfurmycin B

1-Hydroxysulfurmycin B

C43H51NO17 (853.3156836)


   

lacto-n-Fucopentaose III

lacto-n-Fucopentaose III

C32H55NO25 (853.306302)


   

cyclo[2-(1-methylcyclopropyl)-D-glycine-(2S,3aR,8aS)-6,7-dichloro-3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid-erythro-3-hydroxy-D-glutamic acid-O-methyl-L-serine-L-piperazic acid-(S)-2-hydroxy-3,3-dimethylbutanoic acid]|kutzneride 3

cyclo[2-(1-methylcyclopropyl)-D-glycine-(2S,3aR,8aS)-6,7-dichloro-3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid-erythro-3-hydroxy-D-glutamic acid-O-methyl-L-serine-L-piperazic acid-(S)-2-hydroxy-3,3-dimethylbutanoic acid]|kutzneride 3

C37H49Cl2N7O12 (853.2816094000001)


   

Acetylglucosamine|beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|beta-D-galactopyranosyl-(1->3)-[(alpha-L-fucopyranosyl)-(1->4)]-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose sodium salt|beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Gal(beta1-3)[Fuc(alpha1-4)]GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose II (LNF II)|Lewis A pentasaccharide

Acetylglucosamine|beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|beta-D-galactopyranosyl-(1->3)-[(alpha-L-fucopyranosyl)-(1->4)]-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose sodium salt|beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Gal(beta1-3)[Fuc(alpha1-4)]GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose II (LNF II)|Lewis A pentasaccharide

C32H55NO25 (853.306302)


   

alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|alpha-L-Fuc-(1?2)-beta-D-Gal-(1?3)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc|alpha-L-Fucp(1->2)-beta-D-Galp(1->3)-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Fuc(alpha1-2)Gal(beta1-3)GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose I|lacto-neo-fucopentaose|LNF-I

alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc|alpha-L-Fuc-(1?2)-beta-D-Gal-(1?3)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc|alpha-L-Fucp(1->2)-beta-D-Galp(1->3)-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-D-Glcp|Fuc(alpha1-2)Gal(beta1-3)GlcNAc(beta1-3)Gal(beta1-4)Glc|lacto-N-fucopentaose I|lacto-neo-fucopentaose|LNF-I

C32H55NO25 (853.306302)


   

alpha-L-Fuc-(1?2)-beta-D-Gal-(1?4)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc

alpha-L-Fuc-(1?2)-beta-D-Gal-(1?4)-beta-D-GlcNAc-(1?3)-beta-D-Gal-(1?4)-D-Glc

C32H55NO25 (853.306302)


   

Paclitaxel

Paclitaxel

C47H51NO14 (853.3309386)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.310 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.309 Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2]. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2].

   
   

7-Epitaxol

7-epi-Paclitaxel

C47H51NO14 (853.3309386)


7-epi-Taxol is an active metabolite of taxol, with activity comparable to that of taxol against cell replication, promoting microtubule bundle formation and against microtubule depolymerization. 7-epi-Taxol is an active metabolite of taxol, with activity comparable to that of taxol against cell replication, promoting microtubule bundle formation and against microtubule depolymerization.

   

C47H51NO14_Taxol

NCGC00164367-10_C47H51NO14_Taxol

C47H51NO14 (853.3309386)


   

Taxol

Paclitaxel

C47H51NO14 (853.3309386)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CD - Taxanes C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2310 Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2]. Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2].

   
   

LNF III

O-6-Deoxy-alpha-L-galactopyranosyl-(1->3)-O-[beta-delta-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)- D-glucopyranose

C32H55NO25 (853.306302)


   

LNF II

O-6-Deoxy-alpha-L-galactopyranosyl-(1->4)-O-[beta-delta-galactopyranosyl-(1->3)]-O-2-acetamido-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)-delta-glucopyranose

C32H55NO25 (853.306302)


   

LNFP III

O-6-Deoxy-alpha-delta-galactopyranosyl-(1->3)-O-[beta-delta-galactopyranosyl-(1->4)]-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)-O-beta-delta-galactopyranosyl-(1->4)- D-glucose

C32H55NO25 (853.306302)


   

LNF I

lacto-N-fuco-Pentaose I

C32H55NO25 (853.306302)


   

LNFP V

O-6-Deoxy-alpha-L-galactopyranosyl-(1->3)-O-[O-beta-delta-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-delta-glucopyranosyl-(1->3)-beta-delta-galactopyranosyl-(1->4)]-delta-glucose

C32H55NO25 (853.306302)


   
   

Casein

Casein

C47H48N3NaO7S2 (853.2831218000001)


It is used as a food additive .

   
   

(2α,5β,7β,10β)-4,10-Diacetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

(2α,5β,7β,10β)-4,10-Diacetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate

C47H51NO14 (853.3309386)


   

Lacto-N-neofucopentaose I

Lacto-N-neofucopentaose I

C32H55NO25 (853.306302)


   

Brilliant Blue G

Brilliant blue G-250

C47H48N3NaO7S2 (853.2831218000001)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

(MET(O)4,D-LYS8,PHE9)-ACTH (4-9)

(MET(O)4,D-LYS8,PHE9)-ACTH (4-9)

C40H55N9O10S (853.379241)


   

Milataxel

[4-Acetyloxy-15-[3-(furan-2-yl)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-propanoyloxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

C44H55NO16 (853.3520669999999)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   
   

Lnf-III

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

C32H55NO25 (853.306302)


   

beta-D-Glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1-->4)-O-[beta-D-galactopyranosyl-(1-->3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-->3)-O-beta-D-galactopyranosyl-(1-->4)-

beta-D-Glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1-->4)-O-[beta-D-galactopyranosyl-(1-->3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-->3)-O-beta-D-galactopyranosyl-(1-->4)-

C32H55NO25 (853.306302)


   
   

Lewis a pentasaccharide

Lewis a pentasaccharide

C32H55NO25 (853.306302)


   

lacto-N-fucopentose II

lacto-N-fucopentose II

C32H55NO25 (853.306302)


   

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)a-Glc

Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)a-Glc

C32H55NO25 (853.306302)


   

N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

6-deoxy-alpha-L-galactopyranosyl-(1->4)-[alpha-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-alpha-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->4)-[alpha-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-alpha-D-glucopyranose

C32H55NO25 (853.306302)


   

2-[3-[(3S,3S,4R,6S,8R,8aR)-8-[1-azocanyl(oxo)methyl]-6-[2-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-5-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester

2-[3-[(3S,3S,4R,6S,8R,8aR)-8-[1-azocanyl(oxo)methyl]-6-[2-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-5-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester

C50H51N3O10 (853.3574266)


   

Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)Glc

Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)Glc

C32H55NO25 (853.306302)


   

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

C32H55NO25 (853.306302)


   

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

C32H55NO25 (853.306302)


   

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-Glcp

C32H55NO25 (853.306302)


   

WURCS=2.0/5,5,4/[hxFFxh][a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5][a2112h-1a_1-5]/1-2-3-4-5/a6-b1_b4-c1_c2-d1_c3-e1

WURCS=2.0/5,5,4/[hxFFxh][a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][a1221m-1a_1-5][a2112h-1a_1-5]/1-2-3-4-5/a6-b1_b4-c1_c2-d1_c3-e1

C32H55NO25 (853.306302)


   

2-Aminoethyl hexaarabinofuranoside

2-Aminoethyl hexaarabinofuranoside

C32H55NO25 (853.306302)


   

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc

Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(b1-3)]Glc

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(b1-3)]Glc

C32H55NO25 (853.306302)


   

D-Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

D-Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

D-Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc

D-Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

D-Fuc(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

D-Fuc(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)b-Glc

Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)b-Glc

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-4)GalNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)GalNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)b-Glc

C32H55NO25 (853.306302)


   

N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

N-[(3R,4R,5S,6R)-4-Hydroxy-5-[(2S,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-(2,3,4,5,6-pentahydroxyhex-3-enoxy)oxan-3-yl]acetamide

C32H55NO25 (853.306302)


   

Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc

C32H55NO25 (853.306302)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)Gal(b1-4)Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

D-Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

D-Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(a1-3)]Glc

Gal(b1-3)GlcNAc(b1-6)Gal(b1-4)[Fuc(a1-3)]Glc

C32H55NO25 (853.306302)


   

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-3)Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5S,6S)-6-[[(2S,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy]-2-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5S,6S)-6-[[(2S,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy]-2-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-4,5-dihydroxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C32H55NO25 (853.306302)


   

Gal(b1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)b-Glc

Gal(b1-3)GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

Fuc(a1-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

Fuc(a1-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

Gal(b1-3)[D-Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc

C32H55NO25 (853.306302)


   

Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-2Mana

Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-2Mana

C32H55NO25 (853.306302)


   
   

Lacto-N-Fucopentaose II

Lacto-N-Fucopentaose II

C32H55NO25 (853.306302)


   

Lacto-N-fucopentaose V

Lacto-N-fucopentaose V

C32H55NO25 (853.306302)


   

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc

C32H55NO25 (853.306302)


   

6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)]-D-glucopyranose

6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)]-D-glucopyranose

C32H55NO25 (853.306302)


An amino pentasaccharide comprising of beta-D-gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-gal-(1->4)-D-glc in which the D-glc residue is substituted by an alpha-L-Fuc group at position 3. It is found in human milk.

   

tcY-NH2 (TFA)

tcY-NH2 (TFA)

C42H50F3N7O9 (853.3621926)


tcY-NH2 ((trans-Cinnamoyl)-YPGKF-NH2) TFA is a potent selective PAR4 antagonist peptide. tcY-NH2 TFA inhibits thrombin- and AY-NH2-induced platelet aggregation and endostatin release, and can be used in the research of inflammation, immunology[1][2][6].